Berenberg Bank reaffirmed their buy rating on shares of M&G (LON:MNG – Free Report) in a research report released on Monday, MarketBeat Ratings reports. They currently have a GBX 342 price target on the stock.
Other research analysts also recently issued reports about the stock. The Goldman Sachs Group upped their price objective on shares of M&G from GBX 300 to GBX 328 and gave the stock a “buy” rating in a report on Wednesday, January 21st. UBS Group downgraded M&G to a “neutral” rating and upped their price target for the stock from GBX 275 to GBX 290 in a research note on Wednesday, December 17th. JPMorgan Chase & Co. upped their target price on shares of M&G from GBX 305 to GBX 320 and gave the stock a “neutral” rating in a research note on Wednesday, February 4th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a GBX 265 target price on shares of M&G in a research report on Monday, November 10th. Two investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of GBX 290.
Get Our Latest Research Report on MNG
M&G Trading Up 0.1%
M&G Company Profile
M&G plc is a leading savings and investments business, managing investments for both individuals and for large institutional investors, such as pension funds, around the world.
We have a single corporate identity, M&G plc, and two customer-facing brands: Prudential and M&G Investments. Prudential offers savings and insurance for customers in the UK and Europe and for asset management in South Africa. M&G Investments manages assets for clients globally.
With roots stretching back more than 170 years, we have a long history of finding innovative solutions for our customers’ changing needs.
Featured Stories
- Five stocks we like better than M&G
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Trump’s Hand-Written Letter Will Shock his Haters
- Trump’s national nightmare is here
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for M&G Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M&G and related companies with MarketBeat.com's FREE daily email newsletter.
